Follow
Andrea Garofoli
Andrea Garofoli
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Patient-derived xenografts and organoids model therapy response in prostate cancer
S Karkampouna, F La Manna, A Benjak, M Kiener, M De Menna, E Zoni, ...
Nature communications 12 (1), 1-13, 2021
262021
Diagnostic targeted sequencing panel for hepatocellular carcinoma genomic screening
V Paradiso, A Garofoli, N Tosti, M Lanzafame, V Perrina, L Quagliata, ...
The Journal of Molecular Diagnostics 20 (6), 836-848, 2018
132018
The dilemma of HER2 double-equivocal breast carcinomas: genomic profiling and implications for treatment
C Marchiò, P Dell’Orto, L Annaratone, FC Geyer, T Venesio, E Berrino, ...
The American journal of surgical pathology 42 (9), 1190, 2018
102018
Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens
R Servant, M Garioni, T Vlajnic, M Blind, H Pueschel, DC Müller, ...
The Journal of pathology 254 (5), 543-555, 2021
82021
PipeIT: a singularity container for molecular diagnostic somatic variant calling on the Ion Torrent next-generation sequencing platform
A Garofoli, V Paradiso, H Montazeri, PM Jermann, G Roma, L Tornillo, ...
The journal of molecular diagnostics 21 (5), 884-894, 2019
82019
Identification of somatic mutations in thirty-year-old serum cell-free DNA from patients with breast cancer: a feasibility study
M Ritter, V Paradiso, P Widmer, A Garofoli, L Quagliata, ...
Clinical breast cancer 20 (5), 413-421. e1, 2020
42020
The genomic landscape of prostate cancer brain metastases
A Rodriguez, J Gallon, D Akhoundova, S Maletti, A Ferguson, J Cyrta, ...
BioRxiv, 2020
42020
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo‐Independent Regulation of Heat Shock Protein 70 Family Members
M Coto‐Llerena, N Tosti, S Taha‐Mehlitz, V Kancherla, V Paradiso, ...
Hepatology communications 5 (4), 661-674, 2021
32021
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas
L Tornillo, FS Lehmann, A Garofoli, V Paradiso, CKY Ng, S Piscuoglio
Frontiers in oncology, 4014, 2021
12021
Alterations in homologous recombination repair genes in prostate cancer brain metastases
A Rodriguez-Calero, J Gallon, D Akhoundova, S Maletti, A Ferguson, ...
Nature communications 13 (1), 1-10, 2022
2022
Development of novel prostate cancer patient-derived models and applications for translational research
R Servant, M Garioni, T Vlajnic, H Pueschel, DC Müller, T Zellweger, ...
European Urology Open Science 32, S173, 2021
2021
Computational approaches to improve precision oncology
A Garofoli
University_of_Basel, 2021
2021
Personalised organoid drug treatment and therapy resistance characterization based on novel BRCA2 prostate cancer xenograft of SPOP-like phenotype and microsatellite instability
S Karkampouna, F La Manna, MR De Filippo, M De Menna, E Zoni, ...
European Urology Open Science 19, e1822-e1823, 2020
2020
Patient-derived xenograft and organoids models of prostate cancer
S Karkampouna, F la Manna, MR De Filippo, M Kiener, M De Menna, ...
CANCER RESEARCH 80 (11), 64-64, 2020
2020
Abstract B18: Patient-derived xenograft and organoids models of prostate cancer
S Karkampouna, F la Manna, MR De Filippo, M Kiener, M De Menna, ...
Cancer Research 80 (11 Supplement), B18-B18, 2020
2020
PD59-07 PERSONALISED ORGANOID DRUG TREATMENT AND THERAPY RESISTANCE ON NOVEL EARLY ONSET METASTASIS XENOGRAFT MODEL
S Karkampouna, F La Manna, MR De Filippo, M De Menna, E Zoni, ...
The Journal of Urology 203 (Supplement 4), e1207-e1207, 2020
2020
Cost-effective target sequencing panel for hepatocellular carcinoma mutational screening
V Paradiso, A Garofoli, N Tosti, V Perrina, M Lanzafame, L Quagliata, ...
Journal of Hepatology 68, S680, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–17